Suchergebnisse - "Andriole, Gerald L"

PubPharm (510)

1

Novel non-MRI imaging techniques for primary diagnosis of prostate cancer : micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT

enthalten in: Prostate cancer and prostatic diseases | 2024

von Ditonno, F. | Franco, A. | Manfredi, C. | +10

2

Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development

enthalten in: Cancers | 2024

von Barashi, N. | Li, T. | Angappulige, D. | +9

3

Impact of 18F-fluciclovine PET/CT on plans for androgen deprivation therapy in patients with biochemical recurrence of prostate cancer : data analysis from two prospective clinical trials

enthalten in: Urologic oncology | 2023

von Andriole, G. | Scarsbrook, A. | Savir-Baruch, B. | +1

4

Should men undergo MRI before prostate biopsy - CON

enthalten in: Urologic oncology | 2023

von Kim, E. | Andriole, G.

5

Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer

enthalten in: JAMA oncology | 2022

von Halthore, A. | Andriole, G. | Goldstein, M.

CommentOn: JAMA Oncol. 2022 Aug 1;8(8):1128-1136. - PMID 35708696

6

Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Nguyen, D. | Yang, W. | Renganathan, A. | +8

7

The impact of smoking on sexual function

enthalten in: BJU international | 2022

von Mima, M. | Huang, J. | Andriole, G. | +3

8

Reply by Authors

enthalten in: The Journal of urology | 2022

von Andruska, N. | Fischer-Valuck, B. | Waters, M. | +9

CommentOn: J Urol. 2022 Jun;207(6):1234-1235. - PMID 35282698

9

Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy

enthalten in: The Journal of urology | 2022

von Andruska, N. | Fischer-Valuck, B. | Waters, M. | +9

CommentIn: J Urol. 2022 Jun;207(6):1234-1235. - PMID 35282698

10

Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer : Secondary Analysis of a Phase 3 Clinical Trial

enthalten in: European urology | 2022

von Mitra, A. | Narayan, V. | Mokkapati, S. | +42

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[51]